LOCB
ALXA

Lombard Odier & Cie (Bahamas)’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Lombard Odier & Cie (Bahamas)’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-17,500
Closed -$41K – 97
2014
Q3 		$41K Sell
17,500
-31,500
-64% -$120K 0.01% 71
2014
Q2 		$224K Buy
49,000
+1,000
+2% +$4.32K 0.08% 57
2014
Q1 		$213K Buy
48,000
+4,000
+9% +$20.5K 0.08% 58
2013
Q4 		$208K Buy
+44,000
New +$216K 0.08% 63

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HHMI
Howard Hughes Medical Institute Chevy Chase, Maryland $416M AUM 13.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lombard Odier & Cie (Bahamas)'s ALXA Position: Q4 2014 in Review

Lombard Odier & Cie (Bahamas) sold out of Alexza Pharmaceuticals Inc (ALXA) in Q4 2014, closing a stake of 17,500 shares — an estimated $41K sold.

Lombard Odier & Cie (Bahamas) first reported a position in ALXA in Q4 2013 and held it in 4 quarters. The position peaked at $224K in Q2 2014. 31 funds tracked by Wall St. Rank hold ALXA as of Q4 2014.

  • Lombard Odier & Cie (Bahamas) reported no remaining Alexza Pharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • Lombard Odier & Cie (Bahamas) sold 17,500 Alexza Pharmaceuticals Inc shares in Q4 2014, an estimated $41K.
  • Lombard Odier & Cie (Bahamas) first reported a position in Alexza Pharmaceuticals Inc in Q4 2013 and held it in 4 quarters.
  • Lombard Odier & Cie (Bahamas)'s Alexza Pharmaceuticals Inc position peaked at $224K in Q2 2014.
  • 31 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q4 2014.

Based on Lombard Odier & Cie (Bahamas)'s 13F filing for Q4 2014, filed 13 Feb 2015.